Amarnani, R., Travis, S., & Javaid, M. (2020). Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia. Oxford University Press.
Chicago Style (17th ed.) CitationAmarnani, R., S. Travis, and MK Javaid. Novel Use of Burosumab in Refractory Iron-induced FGF23-mediated Hypophosphataemic Osteomalacia. Oxford University Press, 2020.
MLA (9th ed.) CitationAmarnani, R., et al. Novel Use of Burosumab in Refractory Iron-induced FGF23-mediated Hypophosphataemic Osteomalacia. Oxford University Press, 2020.
Warning: These citations may not always be 100% accurate.